InMode (INMD) has released an update.
InMode Ltd., a leader in innovative medical technologies, has announced a new share repurchase program authorizing the buyback of up to 7.68 million ordinary shares, signaling confidence in the company’s long-term prospects despite current economic challenges. The program will utilize InMode’s strong cash reserves, underlining its robust financial position and the board’s proactive response to the stock’s undervalued status. No tax implications are expected from the buyback, and the repurchase actions can be adjusted or halted as deemed necessary.
For further insights into INMD stock, check out TipRanks’ Stock Analysis page.
